From: Priority setting in health care: Lessons from the experiences of eight countries
Country | Principles, guidelines, recommendations |
   Year |  |
   Process |  |
Norway | Priority principles: |
   1987/1997 Lønning Committee I and II |    • Severity |
 |    • Potential effect |
 |    • Cost-effectiveness |
 | Priority groups based on severity (and later funding): |
 |    • Fundamental |
 |    • Supplementary |
 |    • Low priority |
 |    • No public funding |
The Netherlands | Sieves/filters to determine basic package of services: |
   1992/1995 Dutch Committee on Choices in Health Care (Dunning Committee) |    • Is care necessary? |
 |    • Is care efficient? |
 |    • Is care effective? |
 |    • Can care be left up to individual responsibility? |
Sweden | Ethical platform principles: |
   1993/1995 Commission of Parliament members and experts |    • Human dignity |
 |    • Need and solidarity |
 |    • Cost-efficiency |
 | Political/administrative and clinical priority groups: |
 |    • Life-threatening acute diseases, severe chronic diseases and palliative terminal care |
 |    • Prevention and habilitation/rehabilitation |
 |    • Less severe acute diseases |
 |    • Borderline cases |
 |    • Care for reasons other than disease |
Denmark | Core values: |
   1997 Danish Council of Ethics |    • Equal human worth |
 |    • Solidarity |
 |    • Security and safety |
 |    • Freedom and self-determination |
 | General goal, framed in terms of "opportunity for self-expression...irrespective of social background and economic ability" |
 | Partial goals: |
 |    • Social and geographical equity |
 |    • Quality |
 |    • Cost-effectiveness |
 |    • Democracy and consumer influence |
Israel | Criteria for prioritization of recommended technologies: |
   1995 Medical Technology Forum and National Advisory Committee, In response to new National Health Insurance Law |    • Life-saving technology with full recovery |
 |    • Potential to prevent mortality or morbidity |
 |    • Number of patients to benefit |
 |    • Financial burden on society and the patient |
 |    • New technology for diseases with no alternative treatments available |
 |    • Brings increase in longevity and quality of life |
 |    • Benefits of reducing morbidity vs. improving quality of life |
 |    • Net gain is higher than short- or long-term cost |
 |    • Funding of efficacious treatment than is expensive to the individual, but of reasonable cost to society |
New Zealand | Set out principles to guide priority setting decisions: |
   Yearly, beginning in 1993 Core Services Committee/National Health Committee |    • Effectiveness |
 |    • Efficiency |
 |    • Equity |
 |    • Acceptability |
 | 'Consensus conferences' for specialized services; |
 | Recommend core services for given year |
Oregon (US) | Developed Quality of Well-Being Scale; |
   Beginning in 1989 Health Services Commission | Used scale to establish cost-effectiveness rankings; |
 | Revised rankings after public backlash; |
 | Continued to use ranked list of condition-treatment pairs |
 | Recently more emphasis on evidence base for recommendations |
UK | Appraisal of new health technologies; |
   Ongoing, beginning in 1999 National Institute for Clinical Excellence (NICE) | Development of clinical guidelines; |
 | Explicit use of cost-effectiveness evaluations |
 | Appeal possible on narrow grounds |